Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline fosamil + NXL104 vs doripenem in complicated urinary tract infection
2010-022487-12Phase 2Completed
- Sponsor
- Cerexa, Inc
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in complicated urinary tract infection (cUTI) and Symptomatic Bacteriuria comparing Ceftaroline fosamil + NXL104 with Doripenem (2 arms). Started Dec 2010; status: completed.
02
Drugs
ceftaroline fosamilavibactamdoripenem
03
Conditions
complicated urinary tract infection (cUTI)Symptomatic Bacteriuria
Beyond the preview
Go deeper on 2010-022487-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022487-12.